Literature DB >> 6773725

Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children.

G A Burghen, J N Etteldorf, J N Fisher, A Q Kitabchi.   

Abstract

We studied the efficacy of low-dose (0.1 U/kg/h) and high-dose (1..0 U/kg/h) insulin, given randomly to children with diabetic ketoacidosis (DKA) by continuous intravenous infusion without a loading dose. Plasma glucose reached 250 mg/dl in 3.4 +/- 0.4 h with the high-dose insulin group compared with 5.4 +/- 0.5 h with the low-dose insulin group (P < 0.01). During the first 12 h of therapy, plasma glucose fell below 100 mg/dl in 2 of 16 in the low-dose compared with 12 of 16 in the high-dose patients. The decrement of ketone bodies, cortisol, and glucagon was similar in both groups. The number of hours required for HCO3(-) greater than or equal to meq/l and arterial blood pH greater than or equal to 7.30 were not significantly different in the two groups. Hypokalemia (K < 3.4 meq/L) occurred in 3 of 16 low-dose and 10 of 16 high-dose patients. The data show that low-dose insulin, with a slower rate of glucose decrease, is as effective as a high dose for the treatment of DKA in children with less incidence of hypokalemia and decreased potential for hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6773725     DOI: 10.2337/diacare.3.1.15

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Diabetic ketoacidosis: current views on pathogenesis and treatment.

Authors:  U Keller
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

Review 2.  Diabetic ketoacidosis.

Authors:  D G Patel; S C Kalhan
Journal:  Indian J Pediatr       Date:  1986 Sep-Oct       Impact factor: 1.967

3.  Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.

Authors:  Francisco J Pasquel; Katerina Tsegka; Heqiong Wang; Saumeth Cardona; Rodolfo J Galindo; Maya Fayfman; Georgia Davis; Priyathama Vellanki; Alexandra Migdal; Unjali Gujral; K M Venkat Narayan; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2019-11-08       Impact factor: 19.112

4.  Management of diabetic ketoacidosis.

Authors:  Sindhu Sivanandan; Aditi Sinha; Vandana Jain; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2010-12-03       Impact factor: 1.967

Review 5.  Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Authors:  Jean-Louis Chiasson; Nahla Aris-Jilwan; Raphaël Bélanger; Sylvie Bertrand; Hugues Beauregard; Jean-Marie Ekoé; Hélène Fournier; Jana Havrankova
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

6.  Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen.

Authors:  V Sanoe Harrison; Stacy Rustico; Andrew A Palladino; Christine Ferrara; Colin Patrick Hawkes
Journal:  Pediatr Diabetes       Date:  2016-11-03       Impact factor: 4.866

Review 7.  Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; Joseph N Fisher; Mary Beth Murphy; Frankie B Stentz
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  Current concepts and controversies in prevention and treatment of diabetic ketoacidosis in children.

Authors:  Arleta Rewers
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

9.  Insulin dependent diabetes in children.

Authors:  G Jain; G Patel; M J Mehta; B M Shah
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

10.  Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?

Authors:  Abbas E Kitabchi; Mary Beth Murphy; Judy Spencer; Robert Matteri; Jim Karas
Journal:  Diabetes Care       Date:  2008-08-11       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.